Evidence map›Paper›PMID 25740982›Full record

ArticleJournal of virology2015

Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.

Rowena A Bull, Preston Leung, Silvana Gaudieri, Pooja Deshpande, Barbara Cameron, Melanie Walker, Abha Chopra, Andrew R Lloyd, Fabio Luciani

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rowena A BullSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia.
Preston LeungSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia.
Silvana GaudieriSchool of Anatomy, Physiology and Human Biology, University of Western Australia, Nedlands, Western Australia, Australia Institute for Immunology and Infectious Disease, Murdoch University, Perth, Western Australia, Australia.
Pooja DeshpandeSchool of Anatomy, Physiology and Human Biology, University of Western Australia, Nedlands, Western Australia, Australia.
Barbara CameronSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia.
Melanie WalkerSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia.
Abha ChopraInstitute for Immunology and Infectious Disease, Murdoch University, Perth, Western Australia, Australia.
Andrew R LloydSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia.
Fabio LucianiSystems Medicine, Inflammation and Infection Research Centre, School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, New South Wales, Australia luciani@unsw.edu.au.
UNSW Sydney · AUUniversity of Western Australia · AUMurdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe interaction between hepatitis C virus (HCV) and cellular immune responses during very early infection is critical for disease outcome. To date, the impact of antigen-specific cellular immune responses on the evolution of the viral population establishing infection and on potential escape has not been studied. Understanding these early host-virus dynamics is important for the development of a preventative vaccine. Three subjects who were followed longitudinally from the detection of viremia preseroconversion until disease outcome were analyzed. The evolution of transmitted/founder (T/F) viruses was undertaken using deep sequencing. CD8(+) T cell responses were measured via enzyme-linked immunosorbent spot (ELISpot) assay using HLA class I-restricted T/F epitopes. T/F viruses were rapidly extinguished in all subjects associated with either viral clearance (n = 1) or replacement with viral variants leading to establishment of chronic infection (n = 2). CD8(+) T cell responses against 11 T/F epitopes were detectable by 33 to 44 days postinfection, and 5 of these epitopes had not previously been reported. These responses declined rapidly in those who became chronically infected and were maintained in the subject who cleared infection. Higher-magnitude CD8(+) T cell responses were associated with rapid development of immune escape variants at a rate of up to 0.1 per day. Rapid escape from CD8(+) T cell responses has been quantified for the first time in the early phase of primary HCV infection. These rapid escape dynamics were associated with higher-magnitude CD8(+) T cell responses. These findings raise questions regarding optimal selection of immunogens for HCV vaccine development and suggest that detailed analysis of individual epitopes may be required. IMPORTANCE: A major limitation in our detailed understanding of the role of immune response in HCV clearance has been the lack of data on very early primary infection when the transmitted viral variants successfully establish the acute infection. This study was made possible through the availability of specimens from a unique cohort of asymptomatic primary infection cases in whom the first available viremic samples were collected approximately 3 weeks postinfection and at regular intervals thereafter. The study included detailed examination of both the evolution of the viral population and the host cellular immune responses against the T/F viruses. The findings here provide the first evidence of host cellular responses targeting T/F variants and imposing a strong selective force toward viral escape. The results of this study provide useful insight on how virus escapes the host response and consequently on future analysis of vaccine-induced immunity.

Indexed as

Acute DiseaseAdultAmino Acid SequenceAntibodies, ViralCD8-Positive T-LymphocytesDisease ProgressionEpitopes, T-LymphocyteEvolution, MolecularHepacivirusHepatitis AntigensHepatitis CHepatitis C, ChronicHost-Pathogen InteractionsHumansImmunity, CellularMaleAntibodies, ViralEpitopes, T-LymphocyteHepatitis AntigensViral Hepatitis Vaccines

Identifiers

PMID25740982
PMCPMC4442533
OpenAlexW2160974504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.